Holdings

Virtus Biotech Clinical Trials Etf

As of Jul 31, 2026, Virtus Biotech Clinical Trials Etf reported 125 positions worth US$44.2M. Largest: First Tracks Biotherapeutics, Inc., MBX Biosciences, Inc. and AtaiBeckley Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
First Tracks Biotherapeutics, Inc.17,620US$776K+11,481Jul 31, 2026
MBX Biosciences, Inc.8,754US$577K−488Jul 31, 2026
AtaiBeckley Inc.79,289US$569K+14,952Jul 31, 2026
Monopar Therapeutics Inc.5,200US$563K+1,501Jul 31, 2026
Definium Therapeutics, Inc.12,558US$547K−9,435Jul 31, 2026
Xencor, Inc.25,208US$509K+8,501Jul 31, 2026
Zenas BioPharma, Inc.15,697US$494K+8,898Jul 31, 2026
uniQure N.V.11,273US$492K−2,874Jul 31, 2026
Apogee Therapeutics, Inc.3,519US$472K−61Jul 31, 2026
Vor Biopharma Inc.21,644US$458KnewJul 31, 2026